Last reviewed · How we verify

NCT04712630: NIPSAGRAFT

Non-Incised Papillae Surgical Approach (NIPSA) With and Without Graft

Completed NA Last updated 15 January 2021
What this trial tests

NA trial testing Non-incised papila surgical approach without grafting biomaterial in Periodontitis in 24 participants. Completed in 30 December 2020.

Timeline
9 September 2019
Primary endpoint
9 September 2020
30 December 2020

Quick facts

Lead sponsorUniversidad de Murcia
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingquadruple
Primary purposetreatment
Enrollment24
Start date9 September 2019
Primary completion9 September 2020
Estimated completion30 December 2020
Sites1 location across Spain

Drugs / interventions tested

Conditions studied

Sponsor

Universidad de Murcia — full company profile →

Who can join

18 and older, any sex, with Periodontitis or Periodontal Diseases. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study compared the clinical outcomes of the non-incised papila surgical approach (NIPSA) alone and with grafting biomaterial.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Apical approach in periodontal reconstructive surgery with enamel matrix derivate and enamel matrix derivate plus bone substitutes: a randomized, controlled clinical trial.
    Moreno Rodríguez JA, Ortiz Ruiz AJ. · · 2022 · cited 13× · PMID 34791548 · DOI 10.1007/s00784-021-04256-1

Verify or expand the search:

Other recruiting trials for Periodontitis

Currently open trials in the same condition.

Other Universidad de Murcia trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04712630.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing